Neurodevelopment among children under five years with sickle cell disease in Eastern Uganda: A propensity score analysis

AIM: We compared neurodevelopment among children under-five years with and without sickle cell disease in eastern Uganda. METHODS: We conducted a cross-sectional study between March and September 2025 at the pediatric sickle cell clinic of Mbale Regional Referral Hospital. We included 350 children under five years (117 with sickle cell disease and 233 without sickle cell disease). The primary outcome was neurodevelopment assessed using the Malawi Development Assessment Tool. We performed independent sample t-tests to compare development for age z-scores between children with and without sickle cell disease. We used inverse probability of treatment weighting analyses to calculate the effect of sickle cell disease on neurodevelopment. RESULTS: The median age of the children was 40.9 months (interquartile range 27.8 to 54.3 months). Children with sickle cell disease had 0.89 lower DAZ scores compared to their peers without sickle cell disease. Among the children with sickle cell disease, those not enrolled on hydroxyurea had 0.4 lower DAZ scores in the social and language domains compared to those on hydroxyurea. The average exposure effect, obtained from the inverse probability of treatment weighting analyses, was -0.87, 95% CI [-1.19, -0.55] and the average exposure effect among the exposed was - 0.62 95% CI [- 1.01, - 0.23]. CONCLUSION: Children with sickle cell disease had lower developmental scores across all domains (social, gross motor, fine motor and language) compared to community controls. These findings highlight the developmental vulnerability associated with sickle cell disease in early childhood. Efforts towards timely screening and management of developmental delays among children are needed to improve their quality of life and long-term development. This may be through integration of neurodevelopmental screening into routine sickle cell disease care.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-18
DOI
https://doi.org/10.1371/journal.pone.0363134
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Neurodevelopment among children under five years with sickle cell disease in Eastern Uganda: A propensity score analysis

Peter Olupot‐Olupot, Sarah Kiguli, Lawrence Ssegawa, Sarah Mutonyi et al.
1 links
PLoS ONE
Hemoglobinopathies and Related Disorders
article

Neurodevelopment among children under five years with sickle cell disease in Eastern Uganda: A propensity score analysis

Peter Olupot‐Olupot, Sarah Kiguli, Lawrence Ssegawa, Sarah Mutonyi, Milton Wamboko Musaba, Brendah Nambozo, David Mukunya, Julian Abeso, Deogratias Munube, Faith Oguttu, Joel Okwir, Henry K Nabudere, Bernard Maumbe, Susan Lunyolo
article en

Abstract

AIM: We compared neurodevelopment among children under-five years with and without sickle cell disease in eastern Uganda. METHODS: We conducted a cross-sectional study between March and September 2025 at the pediatric sickle cell clinic of Mbale Regional Referral Hospital. We included 350 children under five years (117 with sickle cell disease and 233 without sickle cell disease). The primary outcome was neurodevelopment assessed using the Malawi Development Assessment Tool. We performed independent sample t-tests to compare development for age z-scores between children with and without sickle cell disease. We used inverse probability of treatment weighting analyses to calculate the effect of sickle cell disease on neurodevelopment. RESULTS: The median age of the children was 40.9 months (interquartile range 27.8 to 54.3 months). Children with sickle cell disease had 0.89 lower DAZ scores compared to their peers without sickle cell disease. Among the children with sickle cell disease, those not enrolled on hydroxyurea had 0.4 lower DAZ scores in the social and language domains compared to those on hydroxyurea. The average exposure effect, obtained from the inverse probability of treatment weighting analyses, was -0.87, 95% CI [-1.19, -0.55] and the average exposure effect among the exposed was - 0.62 95% CI [- 1.01, - 0.23]. CONCLUSION: Children with sickle cell disease had lower developmental scores across all domains (social, gross motor, fine motor and language) compared to community controls. These findings highlight the developmental vulnerability associated with sickle cell disease in early childhood. Efforts towards timely screening and management of developmental delays among children are needed to improve their quality of life and long-term development. This may be through integration of neurodevelopmental screening into routine sickle cell disease care.

PLoS ONEVol. 21(11)
Mbale Hospital (UG), Busitema University (UG), Makerere University (UG)
National Institutes of Health, Fogarty International Center
Good health and well-being, Reduced inequalities
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon